Table 2. Convalescent plasma titers from pre-vaccinated participants.
Antigens | Antigen Abbreviation | N | %Titer = 800 | %Titer>800 | Median of Titer |
---|---|---|---|---|---|
SARS-CoV-2 Proteins | NCP | 41 | 22% | 78% | 121,840 |
NTD | 41 | 32% | 68% | 19,932 | |
RBD1 | 41 | 29% | 71% | 24,696 | |
RBD2 | 41 | 27% | 73% | 71,529 | |
ST4 | 41 | 29% | 71% | 98,591 | |
SARS-CoV-2 RBD Mutant Proteins | D614G | 41 | 29% | 71% | 108,678 |
F490S | 41 | 66% | 34% | 800 | |
N460K | 41 | 39% | 61% | 2,655 | |
E484Q | 41 | 41% | 59% | 2,759 | |
Q493R | 41 | 41% | 59% | 3,549 | |
Additional Coronavirus Family Proteins | SARS-CoV-1 | 41 | 5% | 95% | 27,834 |
HKU1 | 41 | 0% | 100% | 143,098 | |
OC43 | 41 | 0% | 100% | 298,107 | |
NL63 | 41 | 0% | 100% | 333,323 | |
229E | 41 | 0% | 100% | 134,673 |